Gastroenterology, Oncology
Numerous evidences demonstrate the involvement of the sex hormone-gut microbiome axis in regulating the antitumor efficacy of ICIs.
10 principles summarizing SynBalance's belief about taking care of people’s health.
Video
Microbiomepost discussed with Nicasio Mancini about the role of gut microbiome in immune response and in the antibiotic resistance.
Gastroenterology
The findings of a recent study suggest that other gut microbes use liquid-liquid phase separation to colonize the gut, opening the way for new microbiota-based clinical applications.
Gastroenterology, Neuroscience
The findings of a recent study suggest that estradiol-degrading bacteria could be therapeutic targets for treating depression in some women.
Industry
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology, which provides greater…
Industry
First and only FDA-approved orally administered microbiota-based therapeutic, validating Seres’ microbiome platform –
Video
Microbiomepost discussed with Vanessa Harris during the MicrobiotaMI congress 2023 about viral interaction with gut microbiome.
Industry
The VE303 study would be the first pivotal Phase 3 study of a therapeutic candidate based on a defined bacterial consortium, which Vedanta is pioneering as a next-generation approach to…
Gastroenterology, Oncology
The findings of a recent study suggest that tilimycin-producing bacteria can cause genetic mutations in the colon and increase a person’s susceptibility to disease.